Changes in type 2 diabetes incidence and mortality associated with introduction of HbA1c as diagnostic option: A Danish 24-year population-based study

BACKGROUND: In 2011, the World Health Organization began recommending glycated haemoglobin (HbA(1c)) as a measure for diagnosing type 2 diabetes (T2D). This initiative may have changed basic T2D epidemiology. Consequently, we examined time changes in T2D incidence and mortality during 1995-2018. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Knudsen, Jakob S., Knudsen, Signe S., Hulman, Adam, Witte, Daniel R., Gregg, Edward W., Lauritzen, Torsten, Pedersen, Lars, Sørensen, Henrik T., Thomsen, Reimar W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733171/
https://www.ncbi.nlm.nih.gov/pubmed/35024680
http://dx.doi.org/10.1016/j.lanepe.2021.100291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733171/
https://www.ncbi.nlm.nih.gov/pubmed/35024680
http://dx.doi.org/10.1016/j.lanepe.2021.100291

Ejemplares similares